nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—Haemoglobin decreased—Crizotinib—lung cancer	0.0261	0.0379	CcSEcCtD
Levosimendan—Haemoglobin decreased—Pemetrexed—lung cancer	0.0238	0.0347	CcSEcCtD
Levosimendan—KCNJ11—mammary gland—lung cancer	0.0221	0.135	CbGeAlD
Levosimendan—Myocardial ischaemia—Pemetrexed—lung cancer	0.0204	0.0297	CcSEcCtD
Levosimendan—KCNJ8—respiratory system—lung cancer	0.0181	0.11	CbGeAlD
Levosimendan—TNNC1—cardiac atrium—lung cancer	0.0167	0.102	CbGeAlD
Levosimendan—Ventricular tachycardia—Pemetrexed—lung cancer	0.0164	0.0239	CcSEcCtD
Levosimendan—KCNJ8—bronchus—lung cancer	0.0149	0.0909	CbGeAlD
Levosimendan—KCNJ8—trachea—lung cancer	0.0134	0.0816	CbGeAlD
Levosimendan—TNNC1—lung—lung cancer	0.0128	0.0782	CbGeAlD
Levosimendan—KCNJ8—cardiac atrium—lung cancer	0.0126	0.0767	CbGeAlD
Levosimendan—Atrial fibrillation—Gefitinib—lung cancer	0.0125	0.0182	CcSEcCtD
Levosimendan—Hypokalaemia—Crizotinib—lung cancer	0.0119	0.0172	CcSEcCtD
Levosimendan—Hypokalaemia—Gefitinib—lung cancer	0.0108	0.0157	CcSEcCtD
Levosimendan—Myocardial ischaemia—Vinorelbine—lung cancer	0.0105	0.0152	CcSEcCtD
Levosimendan—PDE3A—cardiac atrium—lung cancer	0.01	0.0612	CbGeAlD
Levosimendan—KCNJ8—lung—lung cancer	0.00961	0.0587	CbGeAlD
Levosimendan—TNNC1—lymph node—lung cancer	0.00876	0.0535	CbGeAlD
Levosimendan—Myocardial ischaemia—Irinotecan—lung cancer	0.00864	0.0126	CcSEcCtD
Levosimendan—Cardiac disorder—Crizotinib—lung cancer	0.00837	0.0122	CcSEcCtD
Levosimendan—Malnutrition—Crizotinib—lung cancer	0.00785	0.0114	CcSEcCtD
Levosimendan—PDE3A—lung—lung cancer	0.00767	0.0468	CbGeAlD
Levosimendan—Cardiac disorder—Gefitinib—lung cancer	0.0076	0.011	CcSEcCtD
Levosimendan—Angiopathy—Gefitinib—lung cancer	0.00743	0.0108	CcSEcCtD
Levosimendan—Malnutrition—Pemetrexed—lung cancer	0.00717	0.0104	CcSEcCtD
Levosimendan—Malnutrition—Gefitinib—lung cancer	0.00713	0.0104	CcSEcCtD
Levosimendan—Myocardial ischaemia—Paclitaxel—lung cancer	0.00705	0.0103	CcSEcCtD
Levosimendan—Haemoglobin decreased—Docetaxel—lung cancer	0.00698	0.0101	CcSEcCtD
Levosimendan—Extrasystoles—Paclitaxel—lung cancer	0.00673	0.00979	CcSEcCtD
Levosimendan—KCNJ8—lymph node—lung cancer	0.00657	0.0401	CbGeAlD
Levosimendan—Hypokalaemia—Erlotinib—lung cancer	0.00644	0.00936	CcSEcCtD
Levosimendan—Nervous system disorder—Crizotinib—lung cancer	0.00628	0.00913	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Paclitaxel—lung cancer	0.00627	0.00912	CcSEcCtD
Levosimendan—Cardiac failure—Vinorelbine—lung cancer	0.00627	0.00911	CcSEcCtD
Levosimendan—Myocardial ischaemia—Docetaxel—lung cancer	0.00597	0.00869	CcSEcCtD
Levosimendan—Nervous system disorder—Pemetrexed—lung cancer	0.00574	0.00835	CcSEcCtD
Levosimendan—Nervous system disorder—Gefitinib—lung cancer	0.0057	0.00829	CcSEcCtD
Levosimendan—Ventricular tachycardia—Paclitaxel—lung cancer	0.00567	0.00824	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Crizotinib—lung cancer	0.00553	0.00804	CcSEcCtD
Levosimendan—Constipation—Crizotinib—lung cancer	0.00548	0.00796	CcSEcCtD
Levosimendan—Hypotension—Gefitinib—lung cancer	0.00543	0.0079	CcSEcCtD
Levosimendan—KCNJ11—lymph node—lung cancer	0.00535	0.0327	CbGeAlD
Levosimendan—PDE3A—lymph node—lung cancer	0.00525	0.032	CbGeAlD
Levosimendan—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00505	0.00735	CcSEcCtD
Levosimendan—Cardiac failure—Gemcitabine—lung cancer	0.00503	0.00732	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Gefitinib—lung cancer	0.00502	0.0073	CcSEcCtD
Levosimendan—Constipation—Pemetrexed—lung cancer	0.005	0.00728	CcSEcCtD
Levosimendan—Constipation—Gefitinib—lung cancer	0.00497	0.00723	CcSEcCtD
Levosimendan—Tachycardia—Teniposide—lung cancer	0.00463	0.00673	CcSEcCtD
Levosimendan—Hypokalaemia—Irinotecan—lung cancer	0.00459	0.00668	CcSEcCtD
Levosimendan—Angiopathy—Topotecan—lung cancer	0.00449	0.00653	CcSEcCtD
Levosimendan—Hypokalaemia—Gemcitabine—lung cancer	0.00447	0.0065	CcSEcCtD
Levosimendan—Hypotension—Teniposide—lung cancer	0.00443	0.00644	CcSEcCtD
Levosimendan—Diarrhoea—Crizotinib—lung cancer	0.00438	0.00637	CcSEcCtD
Levosimendan—Atrial fibrillation—Paclitaxel—lung cancer	0.00434	0.00631	CcSEcCtD
Levosimendan—Malnutrition—Topotecan—lung cancer	0.00431	0.00626	CcSEcCtD
Levosimendan—Cardiac failure—Etoposide—lung cancer	0.0043	0.00625	CcSEcCtD
Levosimendan—Mental disorder—Erlotinib—lung cancer	0.00429	0.00623	CcSEcCtD
Levosimendan—Malnutrition—Erlotinib—lung cancer	0.00426	0.00619	CcSEcCtD
Levosimendan—Dizziness—Crizotinib—lung cancer	0.00423	0.00616	CcSEcCtD
Levosimendan—Cardiac failure—Paclitaxel—lung cancer	0.00421	0.00613	CcSEcCtD
Levosimendan—Hypokalaemia—Cisplatin—lung cancer	0.00417	0.00606	CcSEcCtD
Levosimendan—Vomiting—Crizotinib—lung cancer	0.00407	0.00592	CcSEcCtD
Levosimendan—Diarrhoea—Pemetrexed—lung cancer	0.004	0.00582	CcSEcCtD
Levosimendan—Diarrhoea—Gefitinib—lung cancer	0.00398	0.00579	CcSEcCtD
Levosimendan—Cardiac disorder—Vinorelbine—lung cancer	0.00393	0.00571	CcSEcCtD
Levosimendan—Dizziness—Pemetrexed—lung cancer	0.00387	0.00563	CcSEcCtD
Levosimendan—Angiopathy—Vinorelbine—lung cancer	0.00384	0.00558	CcSEcCtD
Levosimendan—Nausea—Crizotinib—lung cancer	0.0038	0.00553	CcSEcCtD
Levosimendan—Hypokalaemia—Paclitaxel—lung cancer	0.00374	0.00544	CcSEcCtD
Levosimendan—Vomiting—Pemetrexed—lung cancer	0.00372	0.00541	CcSEcCtD
Levosimendan—Vomiting—Gefitinib—lung cancer	0.0037	0.00538	CcSEcCtD
Levosimendan—Malnutrition—Vinorelbine—lung cancer	0.00368	0.00536	CcSEcCtD
Levosimendan—Atrial fibrillation—Docetaxel—lung cancer	0.00368	0.00535	CcSEcCtD
Levosimendan—Cardiac failure—Docetaxel—lung cancer	0.00357	0.0052	CcSEcCtD
Levosimendan—Nausea—Pemetrexed—lung cancer	0.00348	0.00506	CcSEcCtD
Levosimendan—Nausea—Gefitinib—lung cancer	0.00345	0.00502	CcSEcCtD
Levosimendan—Nervous system disorder—Topotecan—lung cancer	0.00345	0.00501	CcSEcCtD
Levosimendan—Nervous system disorder—Erlotinib—lung cancer	0.00341	0.00496	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Doxorubicin—lung cancer	0.00332	0.00483	CcSEcCtD
Levosimendan—Diarrhoea—Teniposide—lung cancer	0.00324	0.00472	CcSEcCtD
Levosimendan—Cardiac disorder—Irinotecan—lung cancer	0.00324	0.00471	CcSEcCtD
Levosimendan—Angiopathy—Irinotecan—lung cancer	0.00317	0.0046	CcSEcCtD
Levosimendan—Cardiac disorder—Gemcitabine—lung cancer	0.00315	0.00459	CcSEcCtD
Levosimendan—Insomnia—Erlotinib—lung cancer	0.00314	0.00457	CcSEcCtD
Levosimendan—Constipation—Vinblastine—lung cancer	0.00309	0.0045	CcSEcCtD
Levosimendan—Angiopathy—Gemcitabine—lung cancer	0.00308	0.00448	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Topotecan—lung cancer	0.00303	0.00441	CcSEcCtD
Levosimendan—Vomiting—Teniposide—lung cancer	0.00301	0.00438	CcSEcCtD
Levosimendan—Constipation—Topotecan—lung cancer	0.003	0.00437	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Erlotinib—lung cancer	0.003	0.00436	CcSEcCtD
Levosimendan—Ventricular tachycardia—Doxorubicin—lung cancer	0.003	0.00436	CcSEcCtD
Levosimendan—Constipation—Erlotinib—lung cancer	0.00297	0.00432	CcSEcCtD
Levosimendan—Headache—Teniposide—lung cancer	0.00297	0.00432	CcSEcCtD
Levosimendan—Nervous system disorder—Vinorelbine—lung cancer	0.00295	0.00429	CcSEcCtD
Levosimendan—Cardiac disorder—Cisplatin—lung cancer	0.00294	0.00428	CcSEcCtD
Levosimendan—Tachycardia—Vinorelbine—lung cancer	0.00293	0.00427	CcSEcCtD
Levosimendan—Nausea—Teniposide—lung cancer	0.00282	0.00409	CcSEcCtD
Levosimendan—Hypotension—Vinorelbine—lung cancer	0.00281	0.00408	CcSEcCtD
Levosimendan—Malnutrition—Cisplatin—lung cancer	0.00276	0.00401	CcSEcCtD
Levosimendan—Cardiac disorder—Etoposide—lung cancer	0.00269	0.00392	CcSEcCtD
Levosimendan—Cardiac disorder—Paclitaxel—lung cancer	0.00264	0.00384	CcSEcCtD
Levosimendan—Angiopathy—Etoposide—lung cancer	0.00263	0.00383	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00259	0.00377	CcSEcCtD
Levosimendan—Angiopathy—Paclitaxel—lung cancer	0.00258	0.00375	CcSEcCtD
Levosimendan—Constipation—Vinorelbine—lung cancer	0.00257	0.00374	CcSEcCtD
Levosimendan—Mental disorder—Paclitaxel—lung cancer	0.00249	0.00363	CcSEcCtD
Levosimendan—Malnutrition—Paclitaxel—lung cancer	0.00248	0.0036	CcSEcCtD
Levosimendan—Diarrhoea—Vinblastine—lung cancer	0.00247	0.0036	CcSEcCtD
Levosimendan—Nervous system disorder—Irinotecan—lung cancer	0.00243	0.00354	CcSEcCtD
Levosimendan—PDE3A—Platelet homeostasis—PPP2R1B—lung cancer	0.0024	0.0162	CbGpPWpGaD
Levosimendan—Diarrhoea—Topotecan—lung cancer	0.0024	0.0035	CcSEcCtD
Levosimendan—Dizziness—Vinblastine—lung cancer	0.00239	0.00348	CcSEcCtD
Levosimendan—Diarrhoea—Erlotinib—lung cancer	0.00238	0.00346	CcSEcCtD
Levosimendan—Nervous system disorder—Gemcitabine—lung cancer	0.00237	0.00344	CcSEcCtD
Levosimendan—Dizziness—Topotecan—lung cancer	0.00232	0.00338	CcSEcCtD
Levosimendan—Hypotension—Irinotecan—lung cancer	0.00232	0.00337	CcSEcCtD
Levosimendan—Vomiting—Vinblastine—lung cancer	0.0023	0.00334	CcSEcCtD
Levosimendan—Dizziness—Erlotinib—lung cancer	0.0023	0.00334	CcSEcCtD
Levosimendan—Headache—Vinblastine—lung cancer	0.00227	0.0033	CcSEcCtD
Levosimendan—Hypotension—Gemcitabine—lung cancer	0.00226	0.00328	CcSEcCtD
Levosimendan—Insomnia—Irinotecan—lung cancer	0.00224	0.00326	CcSEcCtD
Levosimendan—Cardiac disorder—Docetaxel—lung cancer	0.00224	0.00326	CcSEcCtD
Levosimendan—Vomiting—Topotecan—lung cancer	0.00223	0.00325	CcSEcCtD
Levosimendan—Cardiac failure—Doxorubicin—lung cancer	0.00223	0.00324	CcSEcCtD
Levosimendan—Vomiting—Erlotinib—lung cancer	0.00221	0.00321	CcSEcCtD
Levosimendan—Nervous system disorder—Cisplatin—lung cancer	0.00221	0.00321	CcSEcCtD
Levosimendan—Headache—Topotecan—lung cancer	0.0022	0.0032	CcSEcCtD
Levosimendan—Tachycardia—Cisplatin—lung cancer	0.0022	0.00319	CcSEcCtD
Levosimendan—Angiopathy—Docetaxel—lung cancer	0.00219	0.00318	CcSEcCtD
Levosimendan—Insomnia—Gemcitabine—lung cancer	0.00218	0.00318	CcSEcCtD
Levosimendan—Headache—Erlotinib—lung cancer	0.00218	0.00317	CcSEcCtD
Levosimendan—Nausea—Vinblastine—lung cancer	0.00215	0.00312	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Irinotecan—lung cancer	0.00214	0.00311	CcSEcCtD
Levosimendan—Constipation—Irinotecan—lung cancer	0.00212	0.00308	CcSEcCtD
Levosimendan—Mental disorder—Docetaxel—lung cancer	0.00211	0.00307	CcSEcCtD
Levosimendan—Hypotension—Cisplatin—lung cancer	0.0021	0.00306	CcSEcCtD
Levosimendan—Malnutrition—Docetaxel—lung cancer	0.0021	0.00305	CcSEcCtD
Levosimendan—Nausea—Topotecan—lung cancer	0.00209	0.00304	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00208	0.00303	CcSEcCtD
Levosimendan—KCNJ11—Type II diabetes mellitus—MTOR—lung cancer	0.00208	0.014	CbGpPWpGaD
Levosimendan—Constipation—Gemcitabine—lung cancer	0.00206	0.003	CcSEcCtD
Levosimendan—Nausea—Erlotinib—lung cancer	0.00206	0.003	CcSEcCtD
Levosimendan—Diarrhoea—Vinorelbine—lung cancer	0.00206	0.00299	CcSEcCtD
Levosimendan—Tachycardia—Etoposide—lung cancer	0.00201	0.00293	CcSEcCtD
Levosimendan—Dizziness—Vinorelbine—lung cancer	0.00199	0.00289	CcSEcCtD
Levosimendan—Nervous system disorder—Paclitaxel—lung cancer	0.00198	0.00288	CcSEcCtD
Levosimendan—Hypokalaemia—Doxorubicin—lung cancer	0.00198	0.00288	CcSEcCtD
Levosimendan—Tachycardia—Paclitaxel—lung cancer	0.00197	0.00287	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—CHRNA3—lung cancer	0.00196	0.0132	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Cisplatin—lung cancer	0.00194	0.00283	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—GNG11—lung cancer	0.00193	0.013	CbGpPWpGaD
Levosimendan—Hypotension—Etoposide—lung cancer	0.00193	0.0028	CcSEcCtD
Levosimendan—Vomiting—Vinorelbine—lung cancer	0.00191	0.00278	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—GNG11—lung cancer	0.00189	0.0127	CbGpPWpGaD
Levosimendan—Hypotension—Paclitaxel—lung cancer	0.00189	0.00275	CcSEcCtD
Levosimendan—Headache—Vinorelbine—lung cancer	0.00188	0.00274	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—GNG11—lung cancer	0.00185	0.0125	CbGpPWpGaD
Levosimendan—Insomnia—Paclitaxel—lung cancer	0.00183	0.00266	CcSEcCtD
Levosimendan—Nausea—Vinorelbine—lung cancer	0.00179	0.0026	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Etoposide—lung cancer	0.00178	0.00259	CcSEcCtD
Levosimendan—Constipation—Etoposide—lung cancer	0.00176	0.00256	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00175	0.00254	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—ADCY1—lung cancer	0.00174	0.0117	CbGpPWpGaD
Levosimendan—Constipation—Paclitaxel—lung cancer	0.00173	0.00251	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—AVP—lung cancer	0.00171	0.0115	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.0017	0.0115	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—ADCY1—lung cancer	0.0017	0.0115	CbGpPWpGaD
Levosimendan—Diarrhoea—Irinotecan—lung cancer	0.0017	0.00247	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—PPP2R1B—lung cancer	0.00169	0.0114	CbGpPWpGaD
Levosimendan—Nervous system disorder—Docetaxel—lung cancer	0.00168	0.00244	CcSEcCtD
Levosimendan—Tachycardia—Docetaxel—lung cancer	0.00167	0.00243	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—ADCY1—lung cancer	0.00167	0.0112	CbGpPWpGaD
Levosimendan—Diarrhoea—Gemcitabine—lung cancer	0.00165	0.0024	CcSEcCtD
Levosimendan—Dizziness—Irinotecan—lung cancer	0.00164	0.00238	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HES1—lung cancer	0.00162	0.0109	CbGpPWpGaD
Levosimendan—Cardiac disorder—Methotrexate—lung cancer	0.00161	0.00235	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL10—lung cancer	0.00161	0.0108	CbGpPWpGaD
Levosimendan—Hypotension—Docetaxel—lung cancer	0.0016	0.00233	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—PTHLH—lung cancer	0.00158	0.0107	CbGpPWpGaD
Levosimendan—Angiopathy—Methotrexate—lung cancer	0.00158	0.00229	CcSEcCtD
Levosimendan—Vomiting—Irinotecan—lung cancer	0.00158	0.00229	CcSEcCtD
Levosimendan—Headache—Irinotecan—lung cancer	0.00155	0.00226	CcSEcCtD
Levosimendan—Insomnia—Docetaxel—lung cancer	0.00155	0.00225	CcSEcCtD
Levosimendan—Diarrhoea—Cisplatin—lung cancer	0.00154	0.00224	CcSEcCtD
Levosimendan—Vomiting—Gemcitabine—lung cancer	0.00154	0.00223	CcSEcCtD
Levosimendan—Mental disorder—Methotrexate—lung cancer	0.00152	0.00221	CcSEcCtD
Levosimendan—Malnutrition—Methotrexate—lung cancer	0.00151	0.0022	CcSEcCtD
Levosimendan—Headache—Gemcitabine—lung cancer	0.00151	0.0022	CcSEcCtD
Levosimendan—KCNJ11—Neuronal System—GRIK3—lung cancer	0.0015	0.0101	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Docetaxel—lung cancer	0.00148	0.00215	CcSEcCtD
Levosimendan—Nausea—Irinotecan—lung cancer	0.00147	0.00214	CcSEcCtD
Levosimendan—Constipation—Docetaxel—lung cancer	0.00147	0.00213	CcSEcCtD
Levosimendan—Nausea—Gemcitabine—lung cancer	0.00143	0.00209	CcSEcCtD
Levosimendan—Vomiting—Cisplatin—lung cancer	0.00143	0.00208	CcSEcCtD
Levosimendan—Diarrhoea—Etoposide—lung cancer	0.00141	0.00205	CcSEcCtD
Levosimendan—Cardiac disorder—Doxorubicin—lung cancer	0.0014	0.00203	CcSEcCtD
Levosimendan—Diarrhoea—Paclitaxel—lung cancer	0.00138	0.00201	CcSEcCtD
Levosimendan—Angiopathy—Doxorubicin—lung cancer	0.00137	0.00199	CcSEcCtD
Levosimendan—Dizziness—Etoposide—lung cancer	0.00136	0.00198	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.00136	0.00912	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.00135	0.00909	CbGpPWpGaD
Levosimendan—Dizziness—Paclitaxel—lung cancer	0.00134	0.00194	CcSEcCtD
Levosimendan—Nausea—Cisplatin—lung cancer	0.00134	0.00194	CcSEcCtD
Levosimendan—Mental disorder—Doxorubicin—lung cancer	0.00132	0.00192	CcSEcCtD
Levosimendan—Vomiting—Etoposide—lung cancer	0.00131	0.00191	CcSEcCtD
Levosimendan—Malnutrition—Doxorubicin—lung cancer	0.00131	0.00191	CcSEcCtD
Levosimendan—Headache—Etoposide—lung cancer	0.00129	0.00188	CcSEcCtD
Levosimendan—Vomiting—Paclitaxel—lung cancer	0.00129	0.00187	CcSEcCtD
Levosimendan—Headache—Paclitaxel—lung cancer	0.00127	0.00184	CcSEcCtD
Levosimendan—KCNJ11—Integration of energy metabolism—STK11—lung cancer	0.00124	0.00834	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CHRNB4—lung cancer	0.00122	0.00824	CbGpPWpGaD
Levosimendan—Nausea—Etoposide—lung cancer	0.00122	0.00178	CcSEcCtD
Levosimendan—Nervous system disorder—Methotrexate—lung cancer	0.00121	0.00176	CcSEcCtD
Levosimendan—Nausea—Paclitaxel—lung cancer	0.0012	0.00175	CcSEcCtD
Levosimendan—Diarrhoea—Docetaxel—lung cancer	0.00117	0.00171	CcSEcCtD
Levosimendan—Hypotension—Methotrexate—lung cancer	0.00115	0.00168	CcSEcCtD
Levosimendan—KCNJ11—Neuronal System—CHRNA5—lung cancer	0.00114	0.00766	CbGpPWpGaD
Levosimendan—Dizziness—Docetaxel—lung cancer	0.00113	0.00165	CcSEcCtD
Levosimendan—Insomnia—Methotrexate—lung cancer	0.00112	0.00162	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6R—lung cancer	0.00111	0.00746	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.00111	0.00745	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—AVP—lung cancer	0.0011	0.00738	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KIF5B—lung cancer	0.00109	0.00733	CbGpPWpGaD
Levosimendan—Vomiting—Docetaxel—lung cancer	0.00109	0.00158	CcSEcCtD
Levosimendan—Headache—Docetaxel—lung cancer	0.00107	0.00156	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Methotrexate—lung cancer	0.00107	0.00155	CcSEcCtD
Levosimendan—Nervous system disorder—Doxorubicin—lung cancer	0.00105	0.00153	CcSEcCtD
Levosimendan—Tachycardia—Doxorubicin—lung cancer	0.00104	0.00152	CcSEcCtD
Levosimendan—Nausea—Docetaxel—lung cancer	0.00102	0.00148	CcSEcCtD
Levosimendan—Hypotension—Doxorubicin—lung cancer	0.000999	0.00145	CcSEcCtD
Levosimendan—Insomnia—Doxorubicin—lung cancer	0.000967	0.00141	CcSEcCtD
Levosimendan—KCNJ11—Neuronal System—CHRNA3—lung cancer	0.000928	0.00625	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000923	0.00134	CcSEcCtD
Levosimendan—Constipation—Doxorubicin—lung cancer	0.000915	0.00133	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—KDM1A—lung cancer	0.000895	0.00602	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000879	0.00592	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GNG11—lung cancer	0.000878	0.00591	CbGpPWpGaD
Levosimendan—Diarrhoea—Methotrexate—lung cancer	0.000845	0.00123	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000841	0.00566	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—JUN—lung cancer	0.000817	0.0055	CbGpPWpGaD
Levosimendan—Dizziness—Methotrexate—lung cancer	0.000817	0.00119	CcSEcCtD
Levosimendan—KCNJ11—Neuronal System—ADCY1—lung cancer	0.000789	0.00531	CbGpPWpGaD
Levosimendan—Vomiting—Methotrexate—lung cancer	0.000785	0.00114	CcSEcCtD
Levosimendan—Headache—Methotrexate—lung cancer	0.000774	0.00113	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—EP300—lung cancer	0.000754	0.00507	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CD9—lung cancer	0.00075	0.00505	CbGpPWpGaD
Levosimendan—Nausea—Methotrexate—lung cancer	0.000734	0.00107	CcSEcCtD
Levosimendan—Diarrhoea—Doxorubicin—lung cancer	0.000732	0.00106	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—POMC—lung cancer	0.000729	0.00491	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000714	0.00481	CbGpPWpGaD
Levosimendan—Dizziness—Doxorubicin—lung cancer	0.000707	0.00103	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—BRAF—lung cancer	0.000705	0.00474	CbGpPWpGaD
Levosimendan—Vomiting—Doxorubicin—lung cancer	0.00068	0.000989	CcSEcCtD
Levosimendan—Headache—Doxorubicin—lung cancer	0.00067	0.000974	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—FGR—lung cancer	0.00065	0.00438	CbGpPWpGaD
Levosimendan—Nausea—Doxorubicin—lung cancer	0.000635	0.000924	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—GNG11—lung cancer	0.000615	0.00414	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000594	0.004	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GIPR—lung cancer	0.000593	0.00399	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—MDM2—lung cancer	0.000591	0.00397	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PPIA—lung cancer	0.00059	0.00397	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—RAF1—lung cancer	0.000589	0.00396	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—COL4A3BP—lung cancer	0.000587	0.00395	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AZIN2—lung cancer	0.000587	0.00395	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALDOA—lung cancer	0.000585	0.00394	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFC—lung cancer	0.000585	0.00394	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PPP2R1B—lung cancer	0.000539	0.00363	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GIPR—lung cancer	0.000538	0.00362	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TF—lung cancer	0.000514	0.00346	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GRM8—lung cancer	0.000504	0.00339	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IRF1—lung cancer	0.000503	0.00338	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ATP5H—lung cancer	0.000499	0.00336	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—lung cancer	0.000494	0.00332	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—APP—lung cancer	0.000458	0.00308	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GRM8—lung cancer	0.000458	0.00308	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLBD1—lung cancer	0.000445	0.00299	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AXL—lung cancer	0.00042	0.00282	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—OXTR—lung cancer	0.000415	0.00279	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GRP—lung cancer	0.000415	0.00279	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD17B10—lung cancer	0.000407	0.00274	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GNG11—lung cancer	0.000389	0.00261	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CKB—lung cancer	0.000378	0.00255	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—OXTR—lung cancer	0.000377	0.00254	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GRP—lung cancer	0.000377	0.00254	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ITGB1—lung cancer	0.000366	0.00246	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CNDP2—lung cancer	0.000356	0.00239	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM2—lung cancer	0.000356	0.00239	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GNG11—lung cancer	0.000353	0.00237	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADCY1—lung cancer	0.000349	0.00235	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTMR3—lung cancer	0.000346	0.00233	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PGAM1—lung cancer	0.000337	0.00227	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—BRAF—lung cancer	0.000334	0.00225	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—COL4A2—lung cancer	0.000326	0.0022	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTHLH—lung cancer	0.000325	0.00219	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—HRAS—lung cancer	0.000324	0.00218	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2A7—lung cancer	0.000322	0.00217	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GIPR—lung cancer	0.000318	0.00214	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADCY1—lung cancer	0.000317	0.00214	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SDC4—lung cancer	0.000315	0.00212	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PPP2R1B—lung cancer	0.000309	0.00208	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ANXA1—lung cancer	0.000305	0.00206	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SDC4—lung cancer	0.000297	0.002	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTHLH—lung cancer	0.000295	0.00198	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DUSP3—lung cancer	0.000291	0.00196	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—APP—lung cancer	0.000289	0.00195	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—RRM1—lung cancer	0.000287	0.00193	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA3—lung cancer	0.000287	0.00193	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RHEB—lung cancer	0.000285	0.00192	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MMP1—lung cancer	0.000285	0.00192	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MDM2—lung cancer	0.00028	0.00188	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—RAF1—lung cancer	0.000279	0.00188	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ANXA1—lung cancer	0.000277	0.00187	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—APOA1—lung cancer	0.000272	0.00183	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRM8—lung cancer	0.00027	0.00182	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—B4GALT5—lung cancer	0.00027	0.00181	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—APP—lung cancer	0.000263	0.00177	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA4—lung cancer	0.000262	0.00177	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SKI—lung cancer	0.000262	0.00176	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA2—lung cancer	0.000256	0.00172	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CG—lung cancer	0.000249	0.00167	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA1—lung cancer	0.000247	0.00166	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EGF—lung cancer	0.000246	0.00165	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCC3—lung cancer	0.000244	0.00164	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKR1C1—lung cancer	0.000236	0.00159	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CREBBP—lung cancer	0.000231	0.00155	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—UGT1A1—lung cancer	0.000229	0.00154	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PXN—lung cancer	0.000227	0.00153	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AVP—lung cancer	0.000225	0.00152	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRP—lung cancer	0.000223	0.0015	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKR1C1—lung cancer	0.000223	0.0015	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—OXTR—lung cancer	0.000223	0.0015	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GNG11—lung cancer	0.000221	0.00149	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CD—lung cancer	0.000219	0.00147	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALB—lung cancer	0.000216	0.00145	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDOA—lung cancer	0.00021	0.00142	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNG11—lung cancer	0.000208	0.0014	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AVP—lung cancer	0.000204	0.00138	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOA3—lung cancer	0.000204	0.00138	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ADCY1—lung cancer	0.000199	0.00134	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCG2—lung cancer	0.000199	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFC—lung cancer	0.000198	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RAF1—lung cancer	0.000195	0.00131	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ENO2—lung cancer	0.000195	0.00131	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HPGDS—lung cancer	0.000195	0.00131	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPP2R1B—lung cancer	0.000194	0.0013	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CB—lung cancer	0.000191	0.00128	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—lung cancer	0.000189	0.00127	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADCY1—lung cancer	0.000187	0.00126	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2A6—lung cancer	0.000187	0.00126	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCLC—lung cancer	0.000187	0.00126	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPP2R1B—lung cancer	0.000183	0.00123	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SMARCA4—lung cancer	0.000183	0.00123	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ENO1—lung cancer	0.000177	0.00119	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HSPB1—lung cancer	0.000176	0.00119	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IL2—lung cancer	0.000175	0.00118	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTHLH—lung cancer	0.000174	0.00117	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ANXA1—lung cancer	0.000164	0.0011	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2E1—lung cancer	0.000159	0.00107	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FLT1—lung cancer	0.000159	0.00107	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CG—lung cancer	0.000157	0.00106	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NQO1—lung cancer	0.000157	0.00106	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EP300—lung cancer	0.000157	0.00106	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APP—lung cancer	0.000155	0.00105	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH3—lung cancer	0.000155	0.00105	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF9—lung cancer	0.000154	0.00104	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—HRAS—lung cancer	0.000153	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SRC—lung cancer	0.000153	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—POMC—lung cancer	0.00015	0.00101	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—lung cancer	0.000149	0.001	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JUNB—lung cancer	0.000147	0.00099	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NRAS—lung cancer	0.000147	0.000989	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CG—lung cancer	0.000143	0.00096	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—STK11—lung cancer	0.000142	0.000953	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK3—lung cancer	0.000141	0.000947	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CD—lung cancer	0.000138	0.00093	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—POMC—lung cancer	0.000136	0.000914	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STK11—lung cancer	0.000134	0.000899	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6R—lung cancer	0.000133	0.000892	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTP1—lung cancer	0.000131	0.000882	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FOXO3—lung cancer	0.000129	0.000867	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAT—lung cancer	0.000128	0.000858	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KRAS—lung cancer	0.000126	0.000851	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAP2K1—lung cancer	0.000126	0.00085	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CD—lung cancer	0.000125	0.000844	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCB1—lung cancer	0.000124	0.000835	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TYMS—lung cancer	0.000122	0.00082	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AVP—lung cancer	0.000121	0.000813	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM1—lung cancer	0.00012	0.00081	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CB—lung cancer	0.00012	0.00081	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1R—lung cancer	0.000116	0.000782	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—lung cancer	0.000116	0.000782	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL8—lung cancer	0.000116	0.000779	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HES1—lung cancer	0.000114	0.000769	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1A1—lung cancer	0.000114	0.000768	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ERCC2—lung cancer	0.000113	0.000762	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—lung cancer	0.000112	0.000756	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RAF1—lung cancer	0.000112	0.000754	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL2—lung cancer	0.000111	0.000744	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CB—lung cancer	0.000109	0.000736	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HRAS—lung cancer	0.000107	0.000723	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL8—lung cancer	0.000105	0.000707	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB3—lung cancer	0.000104	0.000703	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL2—lung cancer	0.0001	0.000676	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TERT—lung cancer	0.0001	0.000673	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOA1—lung cancer	9.79e-05	0.000659	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGFR1—lung cancer	9.72e-05	0.000654	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIF1A—lung cancer	9.57e-05	0.000644	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—lung cancer	9.49e-05	0.000639	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOA1—lung cancer	9.23e-05	0.000621	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KDR—lung cancer	9.15e-05	0.000616	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CG—lung cancer	8.94e-05	0.000602	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—POMC—lung cancer	8.51e-05	0.000573	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KIT—lung cancer	8.43e-05	0.000567	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APC—lung cancer	8.43e-05	0.000567	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CG—lung cancer	8.43e-05	0.000567	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—NRAS—lung cancer	8.43e-05	0.000567	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGF—lung cancer	8.33e-05	0.000561	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CREBBP—lung cancer	8.29e-05	0.000558	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAPK3—lung cancer	8.07e-05	0.000543	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—POMC—lung cancer	8.03e-05	0.00054	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BRAF—lung cancer	7.92e-05	0.000533	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CD—lung cancer	7.86e-05	0.000529	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6R—lung cancer	7.83e-05	0.000527	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CREBBP—lung cancer	7.82e-05	0.000526	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALB—lung cancer	7.76e-05	0.000522	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—lung cancer	7.68e-05	0.000517	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAP2K1—lung cancer	7.46e-05	0.000502	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CD—lung cancer	7.41e-05	0.000499	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—lung cancer	7.34e-05	0.000494	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KRAS—lung cancer	7.26e-05	0.000488	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CB—lung cancer	6.85e-05	0.000461	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—lung cancer	6.79e-05	0.000457	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—lung cancer	6.67e-05	0.000449	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MDM2—lung cancer	6.64e-05	0.000447	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAF1—lung cancer	6.62e-05	0.000445	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB2—lung cancer	6.55e-05	0.000441	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CB—lung cancer	6.46e-05	0.000435	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MTOR—lung cancer	6.46e-05	0.000435	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL8—lung cancer	6.21e-05	0.000418	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HRAS—lung cancer	6.17e-05	0.000415	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—lung cancer	6e-05	0.000404	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—lung cancer	5.94e-05	0.0004	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL2—lung cancer	5.93e-05	0.000399	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTEN—lung cancer	5.92e-05	0.000398	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—lung cancer	5.9e-05	0.000397	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCND1—lung cancer	5.78e-05	0.000389	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JUN—lung cancer	5.77e-05	0.000388	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—EP300—lung cancer	5.65e-05	0.00038	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—lung cancer	5.62e-05	0.000378	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1A—lung cancer	5.6e-05	0.000377	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTEN—lung cancer	5.58e-05	0.000376	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—lung cancer	5.45e-05	0.000367	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EP300—lung cancer	5.32e-05	0.000358	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SRC—lung cancer	5.18e-05	0.000348	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—lung cancer	5.04e-05	0.000339	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT3—lung cancer	4.99e-05	0.000336	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NRAS—lung cancer	4.98e-05	0.000335	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK3—lung cancer	4.77e-05	0.000321	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—lung cancer	4.64e-05	0.000312	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—lung cancer	4.54e-05	0.000305	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KRAS—lung cancer	4.29e-05	0.000288	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—lung cancer	4.18e-05	0.000281	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—lung cancer	3.94e-05	0.000265	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—lung cancer	3.81e-05	0.000256	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HRAS—lung cancer	3.64e-05	0.000245	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—lung cancer	3.49e-05	0.000235	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—lung cancer	3.41e-05	0.00023	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—lung cancer	3.22e-05	0.000217	CbGpPWpGaD
